POSTER SESSION 3

1

(DEC)

THE IMPLEMENTATION OF PATIENT DECISION SUPPORT INTERVENTIONS INTO ROUTINE CLINICAL PRACTICE: A SYSTEMATIC REVIEW

Caroline Tietbohl, BA¹, Glyn Elwyn, MD, PhD², Isabelle Scholl, Dipl.-Psych.³, Mala Mann, MInfSc⁴, Adrian Edwards, MB, PhD⁴, Catharine F. Clay, MA, BSN⁵, France Legare, MD, PhD, CCFP, F⁶, Trudy Van der Weijden, MD, PhD⁷, Carmen Lewis, MD, MPH⁸, Richard Wexler, MD⁹ and Dominick Frosch, PhD¹, (1)Palo Alto Medical Foundation Research Institute, Palo Alto, CA, (2)Dartmouth Center for Healthcare Delivery Science, Hanover, NH, (3)University Medical Center Hamburg-Eppendorf, Hamburg, Germany, (4)Cardiff University, Cardiff, United Kingdom, (5)The Dartmouth Center for Health Policy and Clinical Practice, Lebanon, NH, (6)Laval University, Quebec, QC, Canada, (7)Maastricht University, Maastricht, Netherlands, (8)University of North Carolina at Chapel Hill, Chapel Hill, NC, (9)The Foundation for Informed Medical Decision Making, Boston, MA

2

(HSP)

AN AUTOMATED TELEPHONIC SCREENING AND MONITORING SYSTEM FOR DEPRESSION CARE MANAGEMENT: PRELIMINARY FINDINGS FROM A CLINICAL TRIAL

Shinyi Wu, PhD¹, Kathleen Ell, DSW¹, Jeffrey Guterman, MD², Pey-jiuan Lee, MS¹, Irene Vidyanti, MS¹, Caitlin Hawkins, MS¹ and Pai Liu, MS¹, (1)University of Southern California, Los Angeles, CA, (2)Los Angeles County Department of Health Services, Los Angeles, CA

3

(DEC)

TREATMENT PREFERENCES DERIVED USING ADAPTIVE BEST-WORST CONJOINT (ABC) ANALYSIS

Ely Dahan, PhD¹, Sylvia Lambrechts, MPH, MA¹, Robert M. Kaplan, PhD², Catherine M. Crespi, PhD¹, Elizabeth Garcia, BS¹ and Christopher S. Saigal, MD, MPH¹, (1)UCLA, Los Angeles, CA, (2)University of California Los Angeles, Los Angeles, CA

4

(HSP)

* USING SOCIAL MEDIA TO GAUGE REACTION TO THE USPSTF REPORT ON PROSTATE CANCER SCREENING: TWITTER AS AN INVESTIGATIVE TOOL

Vinay Prabhu¹, Ted Lee¹, Herbert Lepor, MD¹, Heather Taffet Gold, PhD¹, John H. Holmes, PhD² and Danil Victor Makarov, MD, MHS¹, (1)New York University School of Medicine, New York, NY, (2)University of Pennsylvania School of Medicine, Philadelphia, PA

5

(DEC)

REACTIONS TO A TARGETED DECISION AID FOR MINORITY PARTICIPATION IN CANCER CLINICAL TRIALS AND ITS EFFECT ON ATTITUDES TOWARDS PARTICIPATION

Margaret M. Byrne, PhD¹, Jamie L. Studts, PhD², Sarah T. Hawley, PhD, MPH³, Colleen Bauza⁴, Heraldo D'Almeida¹, Angela Fagerlin, PhD⁵, Stefan Gluck, MD, PHD¹, Martha Gonzalez¹, Kenneth Goodman¹, Judith Hurley, MD¹, Susan Schmitz¹, Sue Stableford⁶, Andrea Vinard¹ and NIcole Whitehead¹, (1)University of Miami, Miami, FL, (2)University of Kentucky College of Medicine, Lexington, KY, (3)University of Michigan, Ann Arbor VA Health System, Ann Arbor, MI, (4)University of Miami, MIami, FL, (5)VA Ann Arbor Healthcare System & University of Michigan, Ann Arbor, MI, (6)University of New England, Portland, ME

6

(DEC)

DETERMINING MINIMAL CLINICALLY IMPORTANT DIFFERENCE FOR THE PREFERENCE-BASED INSTRUMENTS EUROQOL (EQ-5D) AND QUALITY OF WELL-BEING (QWB) IN POST-TRAUMATIC STRESS DISORDER (PTSD) PATIENTS

Quang A. Le, PharmD, PhD, Western University of Health Sciences, Pomona, CA, Jason N. Doctor, PhD, University of Southern California, Los Angeles, CA, Lori Zoellner, PhD, University of Washington, Seattle, WA and Norah Feeny, PhD, Case Western Reserve University, Cleveland, OH

7

(INF, AHE)

* CENTERING PREGNANCY FOR THE PREVENTION OF PRETERM BIRTH: A COST-EFFECTIVENESS ANALYSIS

Mika Ohno, MD, Santa Clara Valley Medical Center, San Jose, CA, Maria I. Rodriguez, MD, MPH, Oregon Health and Science University, Portland, OR, Sharon Wiener, CNM, UCSF, San Francisco, CA and Aaron B. Caughey, MD, MPP, MPH, PhD, Oregon Health & Sciences University, Portland, OR

8

(HSP)

FACE-TIME VERSUS TEST ORDERING: IS THERE A TRADE-OFF?

James Stahl, MD, CM, MPH, Massachusetts General Hospital, Boston, MA and Mark A. Drew, BID, Massacuhsetts General Hospital, Boston, MA

9

(INF, HSP)

OPTIMIZING OUTPATIENT RESIDENCY TRAINING: BALANCING CLINICAL EXPERIENCE WITH ACCESS TO CARE

Steven D. Overko, MS¹, Hari Balasubramanian, PhD¹, Blair W. Fosburgh, MD² and James Stahl, MD, CM, MPH², (1)University of Massachusetts, Amherst, MA, (2)Massachusetts General Hospital, Boston, MA

10

(HSP)

ELECTRONIC REPORTING TO ASSESS AND IMPROVE VENOUS THROMBOEMBOLISM PROPHYLAXIS

Ximin Li, BMed, MPH, Gail Grant, MD, MPH, MBA, Richard Riggs, MD, Paul Silka, MD and Joshua Pevnick, MD, MSHS, Cedars-Sinai Medical Center, Los Angeles, CA

11

(DEC)

HOW ILLNESS AFFECTS FAMILY MEMBERS: DOMAINS OF WELL-BEING AFFECTED BY “SPILLOVER”

Eve Wittenberg, MPP, PhD¹, Adrianna Saada, MPH¹ and Lisa A. Prosser, M.S., Ph.D.², (1)Harvard School of Public Health, Boston, MA, (2)University of Michigan, Ann Arbor, MI

13

(DEC)

IMPACT OF CAREGIVER STATUS ON HEALTH STATE VALUATIONS

Joseph Johnston¹, Louis Matza², Kristina Boye¹, Lee Bowman¹, Kelly McDaniel², Jessica Jordan² and David Feeny³, (1)Eli Lilly, Indianapolis, IN, (2)United BioSource Corporation, Bethesda, MD, (3)University of Alberta and Health Utilities Incorporated, Portland, OR

14

(HSP)

ALCOHOLISM IS NOT A LIMITING FACTOR TO PATIENT REGISTRATION FOR LIVER TRANSPLANTATION: THE ROLE OF PHYSICIANS OF NON TEACHING PUBLIC HOSPITAL

Victoria Kone, MD, MPH, Hôpitaux Universitaire Paris centre, Paris, France, Christophe Pilette, MD, CHU du Mans, Le mans, France, Yvon Calmus, MD, PhD, Hôpital Saint Antoine, Paris, France and Gwenaelle Vidal-Trecan, MD, PhD, Université Paris Descartes, Faculté de médecine, AP-HP, Paris, France

15

(DEC)

WHEN DO PHYSICIANS RECOMMEND JOINT REPLACEMENT FOR PATIENTS WITH MODERATE DISEASE?

Liana Fraenkel, MD, MPH¹, Lisa G. Suter¹ and Lawrence Weis, MD², (1)Yale School of Medicine, New Haven, CT, (2)VA Connecticut Healthcare System, West Haven, CT

16

(AHE)

* WHEN AND FOR WHOM ARE BIOLOGICS COST-EFFECTIVE IN RHEUMATOID ARTHRITIS?

Hawre Jalal, MD, MSc¹, Kaleb D. Michaud, PhD², François Sainfort, PhD¹, John Schousboe, MD, PhD³, John Nyman, PhD⁴ and Karen M. Kuntz, ScD¹, (1)University of Minnesota, Minneapolis, MN, (2)University of Nebraska Medical Center (UNMC), Omaha, NE, (3)Park Nicollet Health Services; University of Minnesota, Minneapolis, MN, (4)University of Minnesota School of Public Health, Minneapolis, MN

17

(DEC)

DO STARS HELP PATIENTS TO CHOOSE A HOSPITAL FOR SURGERY? A HOSPITAL CHOICE EXPERIMENT

P.J. Marang-van de Mheen, PhD¹, Harm J. Smeets, MD, PhD², Wilma Otten, PhD³, Wendeline J. van der Made, MD¹, Robbert Vree, MD, PhD⁴ and Job Kievit, MD, PhD¹, (1)Leiden University Medical Center, Leiden, Netherlands, (2)Bronovo hospital, The Hague, Netherlands, (3)TNO Quality of life, Leiden, Netherlands, (4)Diaconessenhuis, Leiden, Netherlands

18

(HSP)

* IMPACT OF OBESITY ON FUTURE INCIDENCE OF MALIGNANCIES IN YOUNG ADULTS

Jennifer E. Kim, Terry Therneau, PhD, Ray Kim, MD and Celine Vachon, PhD, Mayo Clinic, Rochester, MN

19

(DEC)

* AN ONLINE TRANSPARENCY PLATFORM ENABLES PREFERENCE-APPROPRIATE BEHAVIOR CHANGE FOR CONSUMERS ON A REFERENCE-BASED PRICING BENEFIT PLAN

Juan Luis S. Marquez, BA¹, Hau Liu, MD, MBA, MS², Mark Hollis, BA², John G. O'Leary, Ph.D.², Sarah K. Metcalf, MBA² and Dena M. Bravata, MD, MS², (1)Stanford University, Stanford, CA, (2)Castlight Health, San Francisco, CA

20

(HSP)

A TALE OF TWO TRIAL DESIGNS: EVALUATION OF EFFICACY VS EFFECTIVENESS IN SCHIZOPHRENIA

Reuven Ferziger, MD¹, Lian Mao, PhD², Joseph Hulihan, MD¹, Cynthia A. Bossie, PhD¹ and Larry Alphs, MD, PhD¹, (1)Janssen Scientific Affairs, LLC, Titusville, NJ, (2)Johnson & Johnson Pharmaceutical Research & Development, LLC, Titusville, NJ

21

(DEC)

THE ADDED BENEFITS OF USING AN INTERACTIVE PATIENT DECISION DASHBOARD

Shirley X.L. Li, BSc¹, Peter J. Veazie, PhD, MS² and James G. Dolan, MD², (1)University of Rochester, Rochester, NY, Canada, (2)University of Rochester, Rochester, NY

22

(AHE)

* ECONOMIC EVALUATIONS OF PERSONALIZED MEDICINE IN ONCOLOGY: WHY ARE THEY SO IMPERSONAL?

Brett M. Doble, M.Sc. and Marcus Tan, B.Pharm, Monash University, Melbourne, Australia

23

(AHE)

* SYSTEMATIC REVIEWS OF ECONOMIC EVALUATIONS: IDENTIFYING, SYNTHESIZING AND PRESENTING EVIDENCE TO AID IN TRANSLATION

Brett M. Doble, M.Sc., Monash University, Clayton, Australia

24

(DEC)

THINKING AHEAD? WILLINGNESS OF THE GENERAL POPULATION TO BE INVOLVED IN ADVANCE CARE PLANNING

Natasja JH Raijmakers, MSc¹, Judith AC Rietjens, PhD¹, Pauline SC Kouwenhoven, MD², Cristiano Vezzoni, Phd³, Ghislaine van Thiel, PhD², Johannes J.M. van Delden, PhD² and A. van der Heide, MD, PhD¹, (1)Erasmus MC University Medical Center, Rotterdam, Netherlands, (2)University Medical Center, Utrecht, Netherlands, (3)University Medical Center, Groningen, Netherlands

25

(INF, AHE)

* COST-EFFECTIVENESS ANALYSIS OF BREAST CANCER SCREENING: DOUBLE READING VERSUS 1 + CAD READING

Miho Sato, MHA¹, Masaaki Kawai, MD, PhD², Yoshikazu Nishino, MD, PhD³ and Tadashi Ishibashi, MD, PhD¹, (1)Tohoku University School of Medicne, Sendai, Miyagi, Japan, (2)Tohoku University Graduate School of Medicne, Sendai, Miyagi, Japan, (3)Miyagi Cancer Center Research Institute, Sendai, Miyagi, Japan

26

(INF, AHE)

THE COST-EFFECTIVENESS OF BECAPLERMIN WHEN USED AS AN ADJUNCT THERAPY WITH GOOD DIABETIC FOOT ULCER CARE

Curtis Waycaster, PhD, Healthpoint Biotherapeutics, Fort Worth, TX

27

(DEC)

CLINICIAN ACCURACY IN PREDICTING SUCCESSFUL VAGINAL BIRTH AFTER CESAREAN: IMPACT OF PATIENT CHARACTERISTICS ON PROVIDER COUNSELING

Katharine Newman, MD, Brigham and Women's Hospital/Massachusetts General Hospital Integrated Residency in Obstetrics and Gynecology, Boston, MA, Bruce Feinberg, MD, Brigham and Women's Hospital, Boston, MA and Anjali Kaimal, MD, MAS, Massachusetts General Hospital, Harvard Medical School, Boston, MA

28

(DEC)

A COMPARISON OF THE WILLINGNESS TO PAY FOR THE PREVENTION OF VISUAL IMPAIRMENT BETWEEN A COMMUNITY BASED SAMPLE AND PEOPLE WITH VISUAL IMPAIRMENT

Steven M. Kymes, Ph.D.¹, Colleen M. Peters, M.A.¹, Adam Turpcu, Ph.D.², P. Kumar Rao, M.D.¹, Rajendra Apte, M.D., Ph.D.³, Kevin J. Blinder, M.D.⁴, Gaurav K. Shah, M.D.⁴, Jamie Kambarian³ and Shoshana Colman², (1)Washington University School of Medicine, Saint Louis, MO, (2)Genentech, Inc., San Francisco, CA, (3)Washington University School of Medicine, St. Louis, MO, (4)The Retina Institute, St. Louis, MO

29

(HSP)

PATIENT-REPORTED SATISFACTION ON USTEKINUMAB TREATMENT COMPARED WITH PRIOR BIOLOGIC THERAPY

Cindy Schmeichel-Mueller, PhD¹, Amir Goren², Marco DiBonaventura², Silas Martin¹ and Brad Schenkel¹, (1)Janssen Scientific Affairs, LLC, Horsham, PA, (2)Kantar Health, New York, NY

30

(HSP)

* ASSESSING HEALTHCARE PROVIDER SATISFACTION OF SERVICES PROVIDED BY THE ARIZONA REGIONAL EXTENSION CENTER (REC): A CROSS-SECTIONAL SURVEY

Derek H. Tang, MS, BSPharm¹, Melissa Rutala, MPH², Connie Ihde², Travis Shank, MBA², April Bills², Lea Mollon, PharmD, Candidate¹ and Terri L. Warholak, PhD, RPh¹, (1)The University of Arizona College of Pharmacy, Tucson, AZ, (2)Arizona Health-e Connection, Phoenix, AZ

31

(HSP)

* DISCHARGE SUMMARIES FREQUENTLY FAIL TO PROVIDE MEDICAL REASONING THAT IS IMPORTANT FOR CONTINUITY OF CARE

Farrant H. Sakaguchi, MD, MS, Michael Strong, MD and Leslie Lenert, MD, MS, University of Utah, Salt Lake City, UT

32

(INF, AHE)

* DECISION MODEL FOR DIABETIC RETINOPATHY DETECTION VIA TELEOPHTHALMOLOGY IN A MIGRANT FARM WORKER POPULATION

Rajeev S. Ramchandran, MD¹, Terry Yonker, RN, MS, FNP-BC², Katia Noyes, PhD, MPH¹ and James G. Dolan, MD¹, (1)University of Rochester, Rochester, NY, (2)Finger Lakes Community Health, Sodus, NY

34

(AHE)

VISUALIZING THE OUTCOMES OF DECISION-ANALYTIC MODELING STUDIES IN THE FRAMEWORK OF HEALTH TECHNOLOGY ASSESSMENT

Ursula Rochau, MD¹, Martina Lackner², Beate Jahn, PhD¹, Gaby Sroczynski, MPH, Dr.PH¹, Kim Saverno, RPh, PhD³, Annette Conrads-Frank, PhD¹, Felicitas Kuehne, MSc⁴, Stephen C. Resch, PhD, MPH⁵ and Uwe Siebert, MD, MPH, MSc, SD⁶, (1)UMIT - University for Health Sciences, Medical Informatics and Technology, ONCOTYROL - Center for Personalized Cancer Medicine, Hall i.T., Austria, (2)UMIT - University for Health Sciences, Medical Informatics and Technology, Hall i.T., Austria, (3)UMIT - University for Health Sciences, Medical Informatics and Technology; University of Utah, Hall i.T., Austria, (4)Oncotyrol - Center for Personalized Cancer Medicine, Innsbruck, Austria, (5)Harvard School of Public Health, Boston, MA, (6)UMIT - University for Health Sciences; ONCOTYROL - Center for Personalized Cancer Medicine; Harvard Univ (HSPH/HMS), Hall i.T., Austria

35

(DEC)

IMPACT OF A NOVEL METHOD OF PATIENT PREFERENCE ELICITATION ON DECISION QUALITY IN MEN WITH PROSTATE CANCER: PILOT DATA

Christopher S. Saigal, MD, MPH¹, Elizabeth Garcia, BS¹, Kate Crespi, PhD¹, Sylvia Lambrechts, MPH, MA¹, Robert M. Kaplan, PhD² and Ely Dahan, PhD¹, (1)UCLA, Los Angeles, CA, (2)University of California Los Angeles, Los Angeles, CA

36

(DEC)

* GIST (NOT VERBATIM) NUMERACY PREDICTS DIABETES MEDICATION ADHERENCE: A FUZZY-TRACE THEORY APPROACH

Priscila G. Brust-Renck, M.A., Valerie Reyna, PhD and Allison Portenoy, Cornell University, Ithaca, NY

37

(HSP)

THE ECONOMIC IMPACT OF ROBOTIC AND OPEN RADICAL PROSTATECTOMY ON PATIENTS AND THEIR FAMILIES

Elena B. Elkin, PhD¹, William T. Lowrance, MD, MPH², Joshua N. Mirkin, BA³, Coral L. Atoria, MPH¹, Peter T. Scardino, MD¹ and James A. Eastham, MD¹, (1)Memorial Sloan-Kettering Cancer Center, New York, NY, (2)Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, (3)State University of New York Downstate College of Medicine, Brooklyn, NY

38

(AHE)

* INTERSECTORAL HEALTH ACTION IN TANZANIA – DETERMINANTS AND POLICY IMPLICATIONS

Michael Simon, MSc, in, Economics, University, of, Freiburg, (Germany), currently, PhD, student, at, University, of, Bonn, (Germany), University of Bonn (Germany), D-53113 Bonn, Germany

39

(HSP)

STAKEHOLDER INPUT TO CLINICAL DECISION SUPPORT (CDS) FOR COMPLEX CHRONIC DISEASE

Mary K. Goldstein, MD, MS¹, Alyssa M. Corley, BA¹, Susana B. Martins, MD, MSc¹, Samson W. Tu, MS², Amy E. Furman, PharmD¹ and Connie M. Oshiro, PhD¹, (1)VA Palo Alto Health Care System, Palo Alto, CA, (2)Stanford University, Stanford, CA

40

(HSP)

VALUE OF INFORMATION AND RESEARCH PRIORITIZATION: OPPORTUNITIES, CHALLENGES, AND AREAS FOR FUTURE DEVELOPMENT

David Rein, PhD, NORC at the University of Chicago, Atlanta, GA

41

(DEC)

DOES UNBLINDING OF TREATMENT ASSIGNMENT IMPACT PARTICIPANT PERCEPTIONS IN CLINICAL TRIALS?

Ann Partridge, MD, MPH¹, Karen R. Sepucha, PhD², Anne O'Neill, M.S.¹, Kathy D. Miller, M.D.³, Christine Motley¹, Ramona F. Swaby, M.D.⁴, Bryan P. Schneider, M.D.³, Chau T. Dang, M.D.⁵, Donald W. Northfelt, M.D.⁶ and George W. Sledge Jr., M.D.³, (1)Dana-Farber Cancer Institute, Boston, MA, (2)Massachusetts General Hospital, Boston, MA, (3)Indiana University Cancer Center, Indianapolis, IN, (4)Fox Chase Cancer Center, Philadelphia, PA, (5)Memorial Sloan-Kettering Cancer Center, New York, NY, (6)Mayo Clinic, Scottsdale, AZ

42

(DEC)

* ONCOLOGISTS' AND NURSES' VIEWS ON THE IMPLEMENTATION OF DECISION AIDS ON SECOND-LINE PALLIATIVE CHEMOTHERAPY IN ROUTINE PRACTICE

Linda J.M. Oostendorp, MSc¹, Petronella B. Ottevanger, MD, PhD¹, Winette T.A. Van der Graaf, Prof, MD¹, Rosella P.M.G. Hermens, PhD¹ and Peep F.M. Stalmeier, PhD², (1)Radboud University Nijmegen Medical Center, Nijmegen, Netherlands, (2)Radboud UMC, Nijmegen, Netherlands

43

(HSP)

* IMAGING STRATEGIES FOR ACUTE APPENDICITIS: EFFECTS OF RADIATION-INDUCED CANCER RISKS

Sorapop Kiatpongsan, MD¹, Ekin Turan, BA², Jonathan D. Eisenberg, BA², Michael E. Gilmore, MBA², Chung Yin Kong, PhD², Laura Avery, MD², G. Scott Gazelle, MD, MPH, PhD² and Pari V. Pandharipande, MD, MPH², (1)Harvard Interfaculty Initiative in Health Policy, Cambridge, MA, (2)Massachusetts General Hospital, Boston, MA

44

(AHE)

PT VS TKA: WEIGHING THE PROS AND CONS

Micah Segelman, Rabbi, MA, James G. Dolan, MD and Katia Noyes, PhD, MPH, University of Rochester, Rochester, NY

45

(INF, HSP)

* MODELS USING MODELS: USE OF MICROSIMULATION MODEL RESULTS TO IMPROVE ACCURACY OF AN EXCEL-BASED POLICY ANALYSIS TOOL FOR USE IN THE FIELD

Jesse D. Ortendahl, BS¹, Andrew D. Clark, MA², Barbara Jauregui, MD, MSc³, Elisa Prieto-Lara, MD⁴, Jane J. Kim, PhD¹ and Stephen C. Resch, PhD, MPH¹, (1)Center for Health Decision Science, Harvard School of Public Health, Boston, MA, (2)London School of Hygiene and Tropical Medicine, London, United Kingdom, (3)ProVac Initiative, Pan American Health Organization, Washington, DC, (4)Pan American Health Organization, Washington, DC

46

(AHE, INF)

COST-BENEFIT ANALYSIS OF PREOPERATIVE SMOKING CESSATION INTERVENTIONS AND POSTOPERATIVE COMPLICATIONS

Ethan Bernstein, MPH, James Iannuzzi, MD and Katia Noyes, PhD, MPH, University of Rochester, Rochester, NY

47

(DEC)

* PARENT AND CHILD HEALTH UTILITIES ASSOCIATED WITH AUTISM SPECTRUM DISORDERS

Tara A. Lavelle, MS, PhD¹, Milton C. Weinstein, PhD², Joseph P. Newhouse, PhD¹, Karen A. Kuhlthau, PhD³, Kerim Munir, MD, MPH, ScD⁴ and Lisa A. Prosser, M.S., Ph.D.⁵, (1)Harvard University, Cambridge, MA, (2)Harvard School of Public Health, Boston, MA, (3)Massachusetts General Hospital, Boston, MA, (4)Children's Hospital Boston, Boston, MA, (5)University of Michigan, Ann Arbor, MI

48

(DEC)

* TIMING DELIVERY OF PLACENTA ACCRETA: A DECISION ANALYSIS

Merrit A. Hoover, PhD, Shahana Baig-Lewis, Rachel A. Pilliod, BS, Brian L. Shaffer, MD, Elizabeth Munro and Aaron B. Caughey, MD, MPP, MPH, PhD, Oregon Health & Sciences University, Portland, OR

49

(HSP)

* USING RFID-BASED REAL-TIME LOCATION SYSTEMS TO DESCRIBE AND UNDERSTAND SOCIAL NETWORKS IN THE OUTPATIENT SETTING

Wilson Wong, PhD¹, Guangying Hua, PhD¹, DOminique M. Haughton, PhD¹ and James Stahl, MD, CM, MPH², (1)Bentley University, Waltham, MA, (2)Massachusetts General Hospital, Boston, MA

50

(DEC)

* EXPLORING USER RESISTANCE AND TECHNOLOGY ADOPTION FACTORS IN HEALTHCARE

Wilson Wong, PhD, Bentley University, Waltham, MA and James Stahl, MD, CM, MPH, Massachusetts General Hospital, Boston, MA

51

(INF, DEC)

* PATIENT DISCORDANCE BETWEEN SURGERY CHOICE AND TREATMENT-RELATED VALUES: A PRELIMINARY STUDY OF BARIATRIC PATIENTS

Andrew L. Weinstein, BS¹, Manish Parikh, MD¹, Bryan J. Marascalchi, BS¹ and Angela Fagerlin, PhD², (1)NYU School of Medicine, New York, NY, (2)VA Ann Arbor Healthcare System & University of Michigan, Ann Arbor, MI

52

(DEC)

BIASES AND HEURISTICS IN MEDICAL DECISION-MAKING: A REVIEW OF THE LITERATURE AND STUDY METHODOLOGIES

Jennifer Blumenthal-Barby, Ph.D. and Heather Krieger, BA, Baylor College of Medicine, Houston, TX

53

(DEC)

* IMPLEMENTING DECISION BOXES IN PRIMARY HEALTHCARE TEAMS TO FACILITATE SHARED DECISION MAKING: BARRIERS AND FACILITATORS

Anik Giguere, PhD¹, Michel Labrecque, MD, PhD², Roland Grad, MD³, Michel Cauchon, MD⁴, Matthew Greenway, MD⁵, France Légaré, MD, PhD⁶, Pierre Pluye, PhD³, Lisa Dolovich, PharmD⁵ and R. Brian Haynes, MD⁵, (1)Health Information Research Unit (HIRU), Hamilton, ON, Canada, (2)Laval University, Quebec, QC, Canada, (3)McGill University, Montreal, QC, Canada, (4)Universite Laval, Quebec, QC, Canada, (5)McMaster University, Hamilton, ON, Canada, (6)CHUQ Research Center-Hospital St-François d'Assise, Knowledge Transfer and Health Technology Assessment, Quebec, QC, Canada